💊 Imatinib 400 Tablets – A Breakthrough in Targeted Cancer Therapy
🧬 Introduction
Imatinib 400 tablets revolutionized cancer treatment by introducing targeted therapy for specific types of blood and gastrointestinal cancers. Unlike traditional chemotherapy, Imatinib precisely targets cancer-causing proteins, improving outcomes and reducing side effects.
Imatinib is widely known under the brand name Gleevec (also called Glivec in many countries).
🧪 What Are Imatinib 400 mg Tablets?
Imatinib is a tyrosine kinase inhibitor (TKI) used to treat cancers driven by abnormal protein activity.
🔍 Common Uses:
- Chronic Myeloid Leukemia (CML)
- Acute Lymphoblastic Leukemia (ALL)
- Gastrointestinal Stromal Tumor (GIST)
👉 It is often prescribed for patients with specific genetic abnormalities like the Philadelphia chromosome.
⚙️ How Imatinib Works
Imatinib targets abnormal proteins such as BCR-ABL, which cause uncontrolled cancer cell growth.
👉 Mechanism:
- Blocks tyrosine kinase enzymes
- Stops cancer cell signaling
- Prevents tumor growth and spread
This targeted action makes it highly effective in long-term cancer control.
💊 Dosage & Administration
- Standard dose: 400 mg once daily (may vary)
- Taken with food and water
- Dose adjusted based on response and tolerance
⚠️ Always take under medical supervision.
⚠️ Side Effects
Common:
- Nausea and vomiting
- Muscle cramps
- Fatigue
- Swelling (edema)
Serious:
- Liver toxicity
- Low blood cell counts
- Heart-related issues (rare)
👉 Regular blood tests are essential during treatment.
